Product Features
- Contains the equine influenza virus (EIV) strains most likely to infect horses: Richmond/07, Ohio/03 and Kentucky/WNV protection for at least 12 months in horses as young as 4 months
- Carbimmune™ adjuvant system minimizes injection site reactions
- Click the link below for more information on what to expect when vaccinating your horse
Description
Horse vaccine from Boehringer Ingelheim as an aid in the prevention of disease caused by Eastern and Western encephalomyelitis and tetanus, as an aid in the prevention of viremia and mortality, as an aid in the reduction of severity of clinical disease caused by West Nile Virus, as an aid in the reduction of respiratory disease caused by equine herpes virus types 1 and 4 (EHV-1 and EHV-4), and as an aid in the reduction of respiratory disease and shedding caused by A2 equine influenza virus.
For vaccination of healthy horses 4 months of age or older. Duration of immunity against equine influenza is at least 6 months, and against West Nile Virus is at least 12 months.
Dosage: 1 ml IM, repeat in 3-4 weeks. Revaccinate annually.
Anaphylactoid reactions may occur. Antidote: Epinephrine.
U.S. Lic. No. 124.
View Manufacturer and/or Label Information:
Helpful Information
Our helpful, friendly and knowledgeable Animal Health Product Experts are ready to serve you, simply...
Email email@pbsanimalhealth.com or call 800-321-0235 to help answer any questions or help you find what you need. We look forward to hearing from you!
Shipping Information for Temperature Sensitive Items
(Vaccines and Other Refrigerated Items)
